POLY Medicure Ltd applies for 8 Patents, 2 FDA approvals (New Kerala)
New Delhi, July 13: Poly Medicure Ltd today said it has applied for eight new patents and two US FDA approvals for its new range of safety syringes and safe blood collection holders.

Teva Will Be Sole Promoter Of Azilect For Parkinson's Disease In The United States (Medical News Today)
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) and Eisai Co., Ltd. (Tokyo Stock Exchange/Osaka Securities Exchange: 4523) today announced that they have mutually agreed to end their May 2003 alliance to co-promote Teva's AZILECT (rasagiline tablets) for Parkinson's disease in the United States. As a result, Teva's U.S. innovative product marketing subsidiary, Teva Neuroscience, Inc. [click